patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · protein
evorpacept
Phase 3updated 2mo agoby $ALXO ALX ONCOLOGY HOLDINGS INC🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Phase 2 3 (across all indications), with 5 investigational indications.
targets
Leukocyte surface antigen CD47
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that